Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,164.08
(
-0.01%
)
US TECH 100
26,515.20
(
-0.15%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
101.76
(
0.22%
)
Bitcoin
76,766.15
(
-2.40%
)
News Focus
News Focus
Post# of 3757
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

go seek

Send PM Follow Ignore
Followers 23
Posts 5149
Boards Moderated 0
Alias Born 06/24/2006

go seek

Re: randychub post# 1273

Friday, 07/06/2007 10:47:04 AM

Friday, July 06, 2007 10:47:04 AM

Post# of 3757
reason for delay...
need efficacy data on triple combination in a larger trial in order to best power any P3 in the future...

also want to test 400 mg dose and controlled use of anti - emetics during first week of treatment.

bottom line, they want want more data to support move to any P3... and feel same is needed in current regulatory environment.

The creation of a thousand forests is in one acorn.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote